본문바로가기
Q
U
I
C
K

Global Innovative Partner of Vaccine and Biotech SK bioscience

From Prevention To Cure
mouse scroll icon SCROLL DOWN

What’s New

  • SK bioscience News SK bioscience Receives Upgrade MSCI...

    SK bioscience acquired an improved MSCI ESG rating from B->BBB in one yearSK bioscience, a global in...

    More
  • News SK bioscience’s World-First Ce...

     ·  The world first cell culture-based influenza ...

    More
  • News SK bioscience Introduces New P...

    - SK bioscience shared a development history of th...

    More
  • News SK bioscience Appoints New Exe...

    - Two biopharmaceutical experts join SK bioscience...

    More
  • News SK bioscience’s Zoster Vaccine...

    -The world-second developed shingles vaccine ‘SKY...

    More

Investor Relations

0 PRESENT PRICE (WON)

0WON

0.00%

Our Products

  • SKYCovione Multi Inj.
  • SKY Cellflu Quadrivalent prefilled syringe
  • SKY Zoster Inj.
  • SKY Varicella Inj.




PRODUCTS SKYCovione Multi Inj.
SKYCovione Multi Inj. image